Literature DB >> 33545745

Chilblain-like lesions and COVID-19: second wave, second outbreak.

V Piccolo1, A Bassi2, T Russo1, C Mazzatenta2, M Baraldi3, G Argenziano1, I Neri4, M Cutrone5.   

Abstract

Entities:  

Year:  2021        PMID: 33545745      PMCID: PMC8014111          DOI: 10.1111/jdv.17145

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


× No keyword cloud information.
Dear Editor, During the first phase of European epidemic of COVID‐19, a contemporary outbreak of chilblain‐like lesions (CLL) has been reported. After that, hundreds of similar cases have been described in the world. CLL typically appeared in young otherwise healthy patients with no proven SARS‐CoV‐2 infection, and most studies did not show positivity of PCR of serology. In Italy, during the trimester March–April–May we experienced the majority of cases of COVID‐19 and contemporarily of CLL. , , During summertime, a dramatic decrease of infected patients was observed, and in that context, CLL were not reported anymore. Unfortunately, a second wave of infections flooded Italy in September and Europe as well. With the fast increase of number of contagions, after a couple of months, novel cases of CLL have reappeared in Italy. We have collected further 15 cases (Fig. 1) in different Italian regions. Patient's profile was the same as the first wave: asymptomatic adolescent (mean age: 14 years) with history of contact with positive patients, but negative swab or serology. Also, morphology of the lesions appeared identical with CLL mostly occurring on the feet (rarely hands) with erythematous–oedematous or blistering lesions. Among these patients, one had a recurrence of CLL after lesions appeared in the first wave.
Figure 1

A 14‐year‐old with chilblain‐like lesions of toes. Lesions presented 1 month prior. The patient was asymptomatic and otherwise healthy. Both serology and PCR were negative.

A 14‐year‐old with chilblain‐like lesions of toes. Lesions presented 1 month prior. The patient was asymptomatic and otherwise healthy. Both serology and PCR were negative. It seems obvious to think that if the second wave is accompanied by a second outbreak of CLL, the relationship is certain. Actually, in most patients a direct or indirect presence of the infection has not been found. This is the first description of the second wave, and cases of CLL are probably expected to increase again. The reason of this phenomenon is still unknown, but two different hypotheses could be advanced. The first and most accepted one supports a relationship with SARS‐CoV‐2 infection, whose contact would induce in young patients a higher innate more than cell‐mediated immune response with consequent fast clearance of antibodies and appearance of CLL. , , , , The second less likely hypothesis is due to immobility; indeed, in Italy the first outbreak was observed during the lockdown and the second outbreak is now occurring during the soft lockdown as well. Young guys are the most affected by these measures because they are not attending schools and spending most of their time sat down watching monitors or TV. The lack of mobility could create a decreased blood flow with consequent appearance of CLL. Although interesting, against this second hypothesis is that frostbite is not among the cutaneous signs observed in paraplegic or wheelchair‐immobilized patients. We would like to share these new data about the second outbreak and need to wait what is going to happen in the next future in order to understand whether the Italian CLL will be followed by the rest of Europe.

Funding source

None.

Conflict of interest

The authors have no financial obligations or conflict of interest to declare. Blistering detachment on the plantar surface of first toe in the same patient.
  11 in total

Review 1.  Are the chilblain-like lesions observed during the COVID-19 pandemic due to severe acute respiratory syndrome coronavirus 2? Systematic review and meta-analysis.

Authors:  V Sánchez-García; R Hernández-Quiles; E de-Miguel-Balsa; A Docampo-Simón; I Belinchón-Romero; J M Ramos-Rincón
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-10-05       Impact factor: 9.228

Review 2.  Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature.

Authors:  Roberto Paparella; Luigi Tarani; Enrico Properzi; Francesco Costantino; Chiara Saburri; Roberta Lucibello; Antonio Richetta; Alberto Spalice; Lucia Leonardi
Journal:  Ital J Pediatr       Date:  2022-06-13       Impact factor: 3.288

3.  BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2.

Authors:  V Piccolo; A Bassi; G Argenziano; C Mazzatenta; M Cutrone; I Neri; R Grimalt; T Russo
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-05-10       Impact factor: 9.228

4.  Contemporary occurrence of Chilblain-like lesions and Pityriasis rosea during the COVID-19 pandemic.

Authors:  V Piccolo; A Bassi; G Argenziano; C Mazzatenta; M Cutrone; I Neri; R Grimalt; T Russo
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-06-07       Impact factor: 9.228

5.  Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic.

Authors:  Marta Bascuas-Arribas; David Andina-Martinez; Juan Añon-Hidalgo; Jose Antonio Alonso-Cadenas; Angela Hernandez-Martin; Nuria Lamagrande-Casanova; Lucero Noguero-Morel; Ana Mateos-Mayo; Isabel Colmenero-Blanco; Antonio Torrelo
Journal:  Pediatr Dermatol       Date:  2022-02-07       Impact factor: 1.997

6.  Detection of a second outbreak of chilblain-like lesions during COVID-19 pandemic through teledermatology.

Authors:  L Giraud-Kerleroux; M Mongereau; C Cassius; M Mrad; C Gary; C Fiani; M Ben Kahla; T Mahevas; E Zuelgaray; C Skayem; C Hua; K Ezzedine; M Bagot; J-D Bouaziz; T A Duong
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-06-04       Impact factor: 9.228

7.  Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle?

Authors:  C Mazzatenta; V Piccolo; G Pace; I Romano; G Argenziano; A Bassi
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-05-28       Impact factor: 9.228

8.  Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccine.

Authors:  N Cameli; M Silvestri; M Mariano; S P Nisticò; A Cristaudo
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-07-24       Impact factor: 9.228

9.  Prognosis of rash and chilblain-like lesions among outpatients with COVID-19: a large cohort study.

Authors:  Hélène Mascitti; Patrick Jourdain; Alexandre Bleibtreu; Luc Jaulmes; Agnès Dechartres; Xavier Lescure; Youri Yordanov; Aurélien Dinh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-07-13       Impact factor: 3.267

Review 10.  A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review.

Authors:  Athanassios Kolivras; Curtis Thompson; Ievgenia Pastushenko; Marisa Mathieu; Pascal Bruderer; Marine de Vicq; Francesco Feoli; Saadia Harag; Isabelle Meiers; Catherine Olemans; Ursula Sass; Florence Dehavay; Ali Fakih; Xuan-Lan Lam-Hoai; Alice Marneffe; Laura Van De Borne; Valerie Vandersleyen; Bertrand Richert
Journal:  J Cutan Pathol       Date:  2021-08-09       Impact factor: 1.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.